Stock listing
NASDAQ:ADAG Adagene, Inc. Stock
Follow Adagene, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ADAG
$2.51 USD -0.17 (-6.3%)
Close on Oct 30, 2026
- Day range
- $2.46 – $2.69 USDOct 30, 2026
- Volume
- 79,571 sharesOct 30, 2026
- Market cap
- $168.5M USDAt the close on Oct 30, 2026 · price × 67.14M shares outstanding
- 52-week range
- $1.30 – $4.85 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $880,476 USDMedian day 225,400 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ADAG · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.51 | -0.17 | -6.3% | $2.67 | $2.69 | $2.46 | 79,571 | |
| $2.68 | +0.01 | +0.4% | $2.72 | $2.72 | $2.60 | 172,571 | |
| $2.67 | +0.09 | +3.5% | $2.75 | $2.78 | $2.61 | 235,602 | |
| $2.58 | +0.09 | +3.6% | $2.625 | $2.67 | $2.44 | 189,230 | |
| $2.49 | +0.08 | +3.3% | $2.42 | $2.55 | $2.34 | 91,197 | |
| $2.41 | -0.03 | -1.2% | $2.42 | $2.57 | $2.295 | 167,165 | |
| $2.44 | +0.03 | +1.2% | $2.385 | $2.50 | $2.275 | 244,219 | |
| $2.41 | -0.09 | -3.6% | $2.55 | $2.55 | $2.39 | 95,527 | |
| $2.50 | +0.21 | +9.2% | $2.30 | $2.50 | $2.30 | 86,627 | |
| $2.29 | +0.23 | +11.2% | $2.04 | $2.29 | $2.01 | 306,389 | |
| $2.06 | -0.34 | -14.2% | $2.40 | $2.40 | $2.01 | 379,601 | |
| $2.40 | +0.11 | +4.8% | $2.31 | $2.42 | $2.26 | 552,483 | |
| $2.29 | -0.17 | -6.9% | $2.35 | $2.50 | $2.25 | 898,863 | |
| $2.46 | -0.28 | -10.2% | $2.73 | $2.73 | $2.435 | 228,500 | |
| $2.74 | -0.02 | -0.7% | $2.77 | $2.855 | $2.68 | 216,500 | |
| $2.76 | -0.02 | -0.7% | $2.76 | $2.87 | $2.625 | 1,649,300 | |
| $2.78 | -0.03 | -1.1% | $2.80 | $3.10 | $2.71 | 240,500 | |
| $2.81 | -0.12 | -4.1% | $2.90 | $3.102 | $2.785 | 173,100 | |
| $2.93 | +0.13 | +4.6% | $2.82 | $3.02 | $2.82 | 213,500 | |
| $2.80 | -0.05 | -1.8% | $2.84 | $2.87 | $2.67 | 325,700 | |
| $2.85 | -0.08 | -2.7% | $2.96 | $3.00 | $2.80 | 298,000 | |
| $2.93 | -0.27 | -8.4% | $3.12 | $3.12 | $2.915 | 278,300 | |
| $3.20 | -0.01 | -0.3% | $3.18 | $3.35 | $3.00 | 254,300 | |
| $3.21 | +0.01 | +0.3% | $3.20 | $3.47 | $2.98 | 492,300 | |
| $3.20 | +0.27 | +9.2% | $2.94 | $3.21 | $2.87 | 528,400 | |
| $2.93 | -0.05 | -1.7% | $2.96 | $3.185 | $2.87 | 196,900 | |
| $2.98 | +0.01 | +0.3% | $2.94 | $3.01 | $2.81 | 317,000 | |
| $2.97 | -0.26 | -8.0% | $3.16 | $3.22 | $2.92 | 208,000 | |
| $3.23 | +0.02 | +0.6% | $3.31 | $3.338 | $3.215 | 226,300 | |
| $3.21 | -0.10 | -3.0% | $3.34 | $3.35 | $3.18 | 97,800 | |
| $3.31 | -0.06 | -1.8% | $3.37 | $3.505 | $3.171 | 287,000 | |
| $3.37 | +0.20 | +6.3% | $3.30 | $3.419 | $3.17 | 260,600 | |
| $3.17 | +0.20 | +6.7% | $3.00 | $3.237 | $2.92 | 319,300 | |
| $2.97 | -0.30 | -9.2% | $3.385 | $3.385 | $2.925 | 626,100 | |
| $3.27 | -0.13 | -3.8% | $3.38 | $3.60 | $3.235 | 155,100 | |
| $3.40 | +0.09 | +2.7% | $3.36 | $3.48 | $3.239 | 258,600 | |
| $3.31 | +0.04 | +1.2% | $3.54 | $3.552 | $3.20 | 224,500 | |
| $3.27 | -0.22 | -6.3% | $3.61 | $3.69 | $3.24 | 267,500 | |
| $3.49 | -0.09 | -2.5% | $3.55 | $3.61 | $3.45 | 193,000 | |
| $3.58 | -0.11 | -3.0% | $3.67 | $3.692 | $3.56 | 28,100 | |
| $3.69 | 0.00 | 0.0% | $3.71 | $3.85 | $3.56 | 167,700 | |
| $3.69 | +0.05 | +1.4% | $3.60 | $3.74 | $3.60 | 102,700 | |
| $3.64 | +0.13 | +3.7% | $3.51 | $3.675 | $3.42 | 120,500 | |
| $3.51 | -0.17 | -4.6% | $3.62 | $3.62 | $3.451 | 131,600 | |
| $3.68 | -0.22 | -5.6% | $3.89 | $3.89 | $3.66 | 123,200 | |
| $3.90 | +0.05 | +1.3% | $3.85 | $3.97 | $3.71 | 296,200 | |
| $3.85 | +0.03 | +0.8% | $3.97 | $4.09 | $3.82 | 122,000 | |
| $3.82 | -0.08 | -2.1% | $3.90 | $3.97 | $3.80 | 63,072 | |
| $3.90 | -0.12 | -3.0% | $3.99 | $4.005 | $3.795 | 159,180 | |
| $4.02 | -0.07 | -1.7% | $4.11 | $4.115 | $3.97 | 61,300 | |
| $4.09 | -0.03 | -0.7% | $4.11 | $4.18 | $4.01 | 205,000 | |
| $4.12 | +0.07 | +1.7% | $4.11 | $4.19 | $4.00 | 278,400 | |
| $4.05 | +0.22 | +5.7% | $3.81 | $4.19 | $3.78 | 332,600 | |
| $3.83 | +0.13 | +3.5% | $3.63 | $3.99 | $3.59 | 1,052,700 | |
| $3.70 | -0.02 | -0.5% | $3.75 | $3.825 | $3.58 | 152,300 | |
| $3.72 | -0.03 | -0.8% | $3.77 | $3.91 | $3.652 | 123,300 | |
| $3.75 | -0.14 | -3.6% | $4.04 | $4.239 | $3.71 | 294,100 | |
| $3.89 | -0.18 | -4.4% | $4.07 | $4.075 | $3.85 | 276,404 | |
| $4.07 | -0.04 | -1.0% | $4.11 | $4.17 | $3.95 | 566,483 | |
| $4.11 | -0.03 | -0.7% | $4.25 | $4.34 | $4.01 | 285,400 | |
| $4.14 | -0.09 | -2.1% | $4.23 | $4.235 | $3.95 | 306,500 | |
| $4.23 | +0.59 | +16.2% | $3.67 | $4.24 | $3.65 | 435,700 | |
| $3.64 | +0.01 | +0.3% | $3.67 | $3.71 | $3.56 | 113,200 | |
| $3.63 | -0.12 | -3.2% | $3.67 | $3.73 | $3.56 | 72,800 | |
| $3.75 | +0.02 | +0.5% | $3.78 | $4.01 | $3.71 | 152,500 | |
| $3.73 | +0.01 | +0.3% | $3.74 | $3.84 | $3.65 | 131,700 |
- Ticker
- NASDAQ:ADAG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 34 slides
Latest news
Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer
Oct 28, 2026
Closed $2.67 (+3.5%) on Oct 28, 2026
Adagene to Participate in the Guggenheim Securities 3rd Annual Healthcare Innovation Conference
Oct 27, 2026
Closed $2.58 (+3.6%) on Oct 27, 2026
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
Apr 2, 2026
Closed $3.99 (-13.4%) on Apr 2, 2026
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)
Dec 16, 2025
Closed $1.90 (+13.8%) on Dec 16, 2025
Decks
Investor Presentation (September 2026)
Investor deck · 34 slides · September 2026
Investor Presentation (July 2023)
Investor deck · 31 slides · Jul 7, 2023
Investor Presentation (January 2022)
Investor deck · 19 slides · Jan 12, 2022
Adagene, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 4 in the last 12 months · 6 in all · newest Oct 28, 2026 · oldest 2025
- Decks
- 3 decks · latest September 2026
Log in to ask 6ix AI your own questions about Adagene, Inc.